Roivant Sciences Ltd.

ROIV70

High Quality

$12.53arrow_drop_up5.92%$0.69

High Quality

ROIV70

$12.53

arrow_drop_up5.92%$0.69

High Quality

Performance History

Key Stats
Open	$11.83
Prev. Close	$11.82
EPS	5.54
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	11.77	12.56
52 Week Range	8.24	13.05

Ratios







EPS	5.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ltd. (ROIV) is a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases with high unmet medical need. The company is dedicated to transforming the traditional drug development process by applying innovative technologies and approaches. Roivant Sciences prides itself on its commitment to delivering transformative medicines to patients in need. The company is driven by a passionate and talented team of scientists, clinicians, and entrepreneurs who are dedicated to improving patients' lives. Roivant Sciences has a diverse pipeline of drug candidates in various stages of development, targeting a range of therapeutic areas including neurology, oncology, and rare diseases.

The stock price history of Roivant Sciences Ltd. (ROIV) has shown significant volatility over the past few years. The stock has experienced both periods of growth and declines, reflecting the inherent risks of investing in the biopharmaceutical industry. Investors should carefully consider the risks and rewards associated with investing in Roivant Sciences Ltd. (ROIV) before making any investment decisions. It is important to note that past performance is not indicative of future results and that the stock price of Roivant Sciences Ltd. (ROIV) can be influenced by numerous factors, including market conditions, regulatory developments, and competitive pressures.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Matthew Gline
Headquarters: London
Employees: 904
Exchange: NASDAQ

Keep an eye on Roivant Sciences Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Roivant Sciences Ltd.'s (ROIV) price per share?

The current price per share for Roivant Sciences Ltd. (ROIV) is $12.53. The stock has seen a price change of $0.7 recently, indicating a 5.92% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Roivant Sciences Ltd. (ROIV)?

For Roivant Sciences Ltd. (ROIV), the 52-week high is $13.06, which is 4.19% from the current price. The 52-week low is $8.24, the current price is 51.97% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Roivant Sciences Ltd. (ROIV) a growth stock?

Roivant Sciences Ltd. (ROIV) has shown an average price growth of -4.13% over the past three years. It has received a score of 80 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Roivant Sciences Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Roivant Sciences Ltd. (ROIV) stock price performance year to date (YTD)?

As of the latest data, Roivant Sciences Ltd. (ROIV) has a year-to-date price change of 10.4%. Over the past month, the stock has experienced a price change of 7.83%. Over the last three months, the change has been 5.47%. Over the past six months, the figure is 14.53%.

help

Is Roivant Sciences Ltd. (ROIV) a profitable company?

Roivant Sciences Ltd. (ROIV) has a net income of $4.23B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 87.53% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.45K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $124.8M, although specific revenue growth data is currently not available. The gross profit is $109.24M. Operating income is noted at $4.24B. Furthermore, the EBITDA is -$1.2B.

help

What is the market capitalization of Roivant Sciences Ltd. (ROIV)?

Roivant Sciences Ltd. (ROIV) has a market capitalization of $9.12B. The average daily trading volume is 12.27, indicating the stock's liquidity and investor engagement.